Patents by Inventor Robert Eugene Burgeson

Robert Eugene Burgeson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Collagen XXII, a novel human collagen and uses thereof
    Patent number: 7452684
    Abstract: The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic-peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: November 18, 2008
    Assignee: The General Hospital Corporation
    Inventors: Robert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman
  • Collagen XXII, a novel human collagen and uses thereof
    Patent number: 7125666
    Abstract: The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: October 24, 2006
    Assignee: The General Hospital Corporation
    Inventors: Robert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman
  • Collagen XXII, a novel human collagen and uses thereof
    Publication number: 20030143564
    Abstract: The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: July 24, 2002
    Publication date: July 31, 2003
    Inventors: Robert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman